Related Experiment Videos
Characterization and validation of electronic medical record data for pharmacoepidemiologic research
Tyler Schneider1,2, Tanvi Punjani1, Jessyca Matos Silva1
1Clinical Pharmacology Research, Research Institute of St Joe's Hamilton, Hamilton, ON, Canada.
Purpose:
Electronic medical records (EMRs) are essential for pharmacoepidemiologic research; however, information on the quality of Canadian hospital EMR data is scarce. We aimed to test data validity in the Epic EMR for key pharmacoepidemiologic themes using QT-prolonging medications and major adverse cardiac events (MACEs) as the research question.
Methods:
An entity relationship diagram (ERD) was developed to navigate >20,000 tables. Computational data validation (comparison with Epic SlicerDicer and Canadian Institute for Health Information Discharge Abstract Database (CIHI-DAD) data) and manual data validation (chart review) were applied with iterative adjustments. Percent agreement with 95% confidence intervals was used to estimate data validity.
Results:
The ERD demonstrated that 43 tables are needed for key pharmacoepidemiologic research data. A cohort of 70,078 adult inpatients was used for computational validation and 2,281 patient charts for manual validation. Demographics (for example, age, sex, gender, admitting service, and critical care transfers); exposures (medication administrations); many potential confounders (lab results, interacting drugs, and electrocardiograms [EKGs]); and most timestamping (admission, medication administrations, death, lab results, and EKGs) were validated with >95% agreement. Inadequate agreement for MACE (other than death) brought the primary outcome MACE agreement to <90%, requiring patient-level linkage to CIHI-DAD to improve agreement. Comorbidities, including hypertension and heart failure, also required this linkage.
Conclusion:
A world-leading proprietary EMR after the painstaking development of an ERD and validation of key data fields showed that not all data are of sufficient quality for pharmacoepidemiologic research. Linked human-coded data are required for some diagnoses.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Measurement of Bioavailability: Pharmacodynamic Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Dosage Regimens: Partial Pharmacokinetic Parameters